Bayer Aktiengesellschaft (ETR:BAYN) Stock Price Down 1.3% – Should You Sell?

Bayer Aktiengesellschaft (ETR:BAYN) traded down 1.3% during trading on Tuesday . The company traded as low as €19.22 ($20.23) and last traded at €19.50 ($20.53). 4,583,339 shares were traded during trading, The stock had previously closed at €19.76 ($20.80).

Bayer Aktiengesellschaft Stock Performance

The company has a market cap of $18.99 billion, a PE ratio of -15.12, a P/E/G ratio of 36.39 and a beta of 0.97. The company has a quick ratio of 0.72, a current ratio of 1.27 and a debt-to-equity ratio of 129.94. The stock’s 50 day simple moving average is €22.76 and its two-hundred day simple moving average is €25.79.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.